Argenx Se (ARGX) Assets Growth (5y) (2020 - 2025)

Argenx Se (ARGX) Assets Growth (5y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 31.42%
Jun 30, 2025 -68.26%
Dec 31, 2024 31.35%
Jun 30, 2024 33.44%
Dec 31, 2023 47.07%
Jun 30, 2023 49.36%
Dec 31, 2022 48.32%
Jun 30, 2022 73.96%
Dec 31, 2021 90.30%
Dec 31, 2020 113.12%